Introduction: Gastric cancer has a poor prognosis. It is the fifth most common cancer in terms of incidence and the fourth most common cancer in terms of mortality world wide. The aim of our study is to identify the clinical and pathological factors associated with survival and predictive of death. Method: Our study included 262 patients over a 13-year periodfrom 2007 to 2020 at Aristide Le Dantec Hospital in Senegal and Conakry Hospital in Guinea. The survival period was established from one month after treatment to the date of death or last news. We first used the Cox proportional hazard model to identify independent factors associated with survival. Then we applied logistic regression to these factors to develop the prognostic equation. Results:The overall survival at 6 months, 1 year and 5 years after treatment was respectively 74%, 57%, 38%. The probability of occurrence of death after 5 years can be estimated with 93\% accuracy, by: log (π i / (1 -π i )) = -19,983 + 2,119* Métastases + 1,268* Ulcère gastrique + 1,100* Tabac + 37,646* Epigastralgie + 37,563* Cardiopathie + 37,220*Mucineux. Conclusion: Our approach contributes to determine the impact of clinical and pathological factors on the survival of patients and the eventual occurrence of death related to stomach cancer.
Pedicle torsion is the most common complication of ectopic spleen. The observation we bring was the case of a 20 year old lady admitted to the emergency room with an acute surgical abdomen picture evolving for about two years. Clinical examination revealed generalized abdominal pain and a mass in the right iliac fossa. The torsion of the spleen was suspected by the clinic, the abdomino-pelvic ultrasound and confirmed during an exploratory laparotomy. Intraoperatively the spleen was necrotic on a long twisted pedicle indicating a splenectomy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.